Pulse of The Hill

Loading navigation…

LOBBYIST

Maren McBride

Registrant in 2026 disclosures: Dla Piper LLP (US)

Based on 12 cached source filings; newest posted Oct 19, 2026. Disclosure history is not real-time employment verification.

← Back to lobbyists

Following Maren McBride’s registrations? Leave your email and we’ll follow up personally when their filings change.

25ACTIVITIES
9DISCLOSED CLIENTS
3BILLS

Revolving door — covered positions

Prior government positions reported in lobbying disclosures. These are historical roles, not a statement of current employment.

Counsel, Rep. Mollohan

Disclosed clients

9

Clients named in filings listing Maren, across all filing years. Activity counts are disclosure mentions, not a list of current engagements.

Pharmaceutical Research and Manufacturers of America7 activities
Avalyn Pharma Inc.4 activities

+ 7 more disclosed clients — available with full intelligence access

Limited preview · paid research

See the research behind a profile.

Connect disclosed clients, bills and source filings. The full federal calendar and records stay paid.

Separate example—not a dossier about this person, an endorsement or proof of participation.

Federal Intelligence: $2,500 one-time for three months or $9,000 for twelve months prepaid. One named user; no automatic renewal.

Secure setup within one business day after verified payment. Your term starts at activation.

Only need a finished deliverable? Commission a focused federal research brief · $1,000 one-time →. Scope agreed before payment; no account access included.

Account options and coverage

Unlock the full client and employer history, complete bill and issue activity, professional contact sources where available, and the joined map of where this lobbyist appears across the Pulse database. Missing contacts are not presented as verified.

A free alert subscription does not grant full access.

Bill references in disclosures

3

An explicitly named Congress takes precedence; otherwise the Congress is estimated from the filing year. Consult the original filing before relying on a historical reference.

+ 1 more bill referenced in their activities — available with full intelligence access

Topics in Filings

11

Policy topics Maren files on across all their LD-2 activities.

CMS TEAM model, value-based care arrangements×2

+ 10 more topics in the full dossier

Pulled from the org’s own LD-2 disclosures. See the source filings ↓

Source filing samples

Most recent available disclosure for each client shown above. Consult the original filing to verify context; these samples are not the complete filing history.

Pharmaceutical Research and Manufacturers of America · 2026 first_quarter filing ↗

Avalyn Pharma Inc. · 2026 third_quarter filing ↗

Issue mix

LDA general-issue codes weighted by activity count.

Health Issues8
Medicare/Medicaid5
Medical/Disease Research/Clinical Labs5

+ 6 more issue areas in the full intelligence view

Is this you? Claim or correct this profile.